{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:05:50Z","timestamp":1778047550936,"version":"3.51.4"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s10822-011-9478-1","type":"journal-article","created":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T13:47:11Z","timestamp":1321969631000},"page":"1095-1106","source":"Crossref","is-referenced-by-count":139,"title":["Qualitative prediction of blood\u2013brain barrier permeability on a large and refined dataset"],"prefix":"10.1007","volume":"25","author":[{"given":"Markus","family":"Muehlbacher","sequence":"first","affiliation":[]},{"given":"Gudrun M.","family":"Spitzer","sequence":"additional","affiliation":[]},{"given":"Klaus R.","family":"Liedl","sequence":"additional","affiliation":[]},{"given":"Johannes","family":"Kornhuber","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,11,23]]},"reference":[{"issue":"4","key":"9478_CR1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1113\/expphysiol.1993.sp003698","volume":"78","author":"MWB Bradbury","year":"1993","unstructured":"Bradbury MWB (1993) The blood-brain barrier. Exp Physiol 78(4):453\u2013472","journal-title":"Exp Physiol"},{"issue":"6","key":"9478_CR2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/cn100007x","volume":"1","author":"TT Wager","year":"2010","unstructured":"Wager TT, Chandrasekaran RY, Hou X, Troutman MD, Verhoest PR, Villalobos A, Will Y (2010) Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes. ACS Chem Neurosci 1(6):420\u2013434. doi: 10.1021\/cn100007x","journal-title":"ACS Chem Neurosci"},{"issue":"11\u201312","key":"9478_CR3","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.drudis.2011.04.004","volume":"16","author":"PA Nielsen","year":"2011","unstructured":"Nielsen PA, Andersson O, Hansen SH, Simonsen KB, Andersson G (2011) Models for predicting blood-brain barrier permeation. Drug Discov Today 16(11\u201312):472\u2013475","journal-title":"Drug Discov Today"},{"key":"9478_CR4","first-page":"8","volume":"24","author":"O Lacombe","year":"2010","unstructured":"Lacombe O, Guyol AC, Videau O, Pruvost A, Bolze S, Prevost C, Mabondzo A (2010) Brain penetration predictivity using in vitro primary rat and human cell-based blood-brain barrier models for drug discovery and development. Fundam Clin Pharmacol 24:8","journal-title":"Fundam Clin Pharmacol"},{"issue":"7\u20138","key":"9478_CR5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.drudis.2007.12.007","volume":"13","author":"W Muster","year":"2008","unstructured":"Muster W, Breidenbach A, Fischer H, Kirchner S, M\u00fcller L, P\u00e4hler A (2008) Computational toxicology in drug development. Drug Discov Today 13(7\u20138):303\u2013310","journal-title":"Drug Discov Today"},{"issue":"1\u20132","key":"9478_CR6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drudis.2006.10.013","volume":"12","author":"WM Pardridge","year":"2007","unstructured":"Pardridge WM (2007) Blood-brain barrier delivery. Drug Discov Today 12(1\u20132):54\u201361","journal-title":"Drug Discov Today"},{"issue":"9","key":"9478_CR7","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.4155\/fmc.09.137","volume":"1","author":"DD Stenehjem","year":"2009","unstructured":"Stenehjem DD, Hartz AM, Bauer B, Anderson GW (2009) Novel and emerging strategies in drug delivery for overcoming the blood brain barrier. Futur Med Chem 1(9):1623\u20131641. doi: 10.4155\/fmc.09.137","journal-title":"Futur Med Chem"},{"issue":"1\u20132","key":"9478_CR8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jns.2009.02.045","volume":"283","author":"BO Popescu","year":"2009","unstructured":"Popescu BO (2009) Pathological changes of the blood-brain barrier in dementias. J Neurol Sci 283(1\u20132):250","journal-title":"J Neurol Sci"},{"issue":"Suppl 3","key":"9478_CR9","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1471-2202-9-S3-S2","volume":"9","author":"WA Banks","year":"2008","unstructured":"Banks WA (2008) Developing drugs that can cross the blood-brain barrier: applications to Alzheimer\u2019s disease. BMC Neurosci 9(Suppl 3):S2","journal-title":"BMC Neurosci"},{"issue":"2","key":"9478_CR10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0031-6997(24)01320-6","volume":"49","author":"V HEd","year":"1997","unstructured":"HEd V, Kuiper J, AGd B, Berkel TJCV, Breimer DD (1997) The blood-brain barrier in neuroinflammatory diseases. Pharmacol Rev 49(2):143\u2013156","journal-title":"Pharmacol Rev"},{"key":"9478_CR11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1568005053174672","volume":"5","author":"A Jong","year":"2005","unstructured":"Jong A, Huang S-H (2005) Blood-brain barrier drug discovery for central nervous system infections. Curr Drug Targ Infect Disord 5:65\u201372","journal-title":"Curr Drug Targ Infect Disord"},{"issue":"1","key":"9478_CR12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1602\/neurorx.2.1.15","volume":"2","author":"U Bickel","year":"2005","unstructured":"Bickel U (2005) How to measure drug transport across the blood-brain barrier. NeuroRX 2(1):15\u201326","journal-title":"NeuroRX"},{"issue":"5","key":"9478_CR13","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1111\/j.1471-4159.1990.tb01236.x","volume":"54","author":"M-P Dehouck","year":"1990","unstructured":"Dehouck M-P, M\u00e9resse S, Delorme P, Fruchart J-C, Cecchelli R (1990) An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro. J Neurochem 54(5):1798\u20131801. doi: 10.1111\/j.1471-4159.1990.tb01236.x","journal-title":"J Neurochem"},{"key":"9478_CR14","doi-asserted-by":"crossref","unstructured":"Fricker G (2008) In vitro models to study blood-brain barrier function. In: Ehrhardt C, Kim KJ (ed) Drug absorption studies: in situ, in vitro and in silico models, vol VII. Biotechnology: pharmaceutical aspects. Springer, US, pp 397\u2013417. doi: 10.1007\/978-0-387-74901-3_17","DOI":"10.1007\/978-0-387-74901-3_17"},{"issue":"3","key":"9478_CR15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/mp1004614","volume":"8","author":"O Lacombe","year":"2011","unstructured":"Lacombe O, Videau O, Chevillon D, Guyot A-C, Contreras C, Blondel S, Nicolas L, Ghettas A, Benech H, Thevenot E, Pruvost A, Bolze S, Krzaczkowski L, Prevost C, As M (2011) In vitro primary human and animal cell-based blood-brain barrier models as a screening tool in drug discovery. Mol Pharm 8(3):651\u2013663. doi: 10.1021\/mp1004614","journal-title":"Mol Pharm"},{"issue":"2","key":"9478_CR16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1248\/bpb.24.111","volume":"24","author":"T Terasaki","year":"2001","unstructured":"Terasaki T, Hosoya K-I (2001) Conditionally immortalized cell lines as a new in vitro model for the study of barrier functions. Biol Pharm Bull 24(2):111\u2013118","journal-title":"Biol Pharm Bull"},{"key":"9478_CR17","doi-asserted-by":"crossref","unstructured":"Boje KMK (2001) In vivo measurement of blood-brain barrier permeability. In: Current protocols in neuroscience. Wiley. doi: 10.1002\/0471142301.ns0719s15","DOI":"10.1002\/0471142301.ns0719s15"},{"issue":"6","key":"9478_CR18","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/jps.21580","volume":"98","author":"L Di","year":"2009","unstructured":"Di L, Kerns EH, Bezar IF, Petusky SL, Huang YP (2009) Comparison of blood-brain barrier permeability assays: in situ brain perfusion, MDR1-MDCKII and PAMPA-BBB. J Pharm Sci 98(6):1980\u20131991","journal-title":"J Pharm Sci"},{"issue":"1\u20132","key":"9478_CR19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijpharm.2010.05.037","volume":"395","author":"J Mensch","year":"2010","unstructured":"Mensch J, LJ L, Sanderson W, Melis A, Mackie C, Verreck G, Brewster ME, Augustijns P (2010) Application of PAMPA-models to predict BBB permeability including efflux ratio, plasma protein binding and physicochemical parameters. Int J Pharm 395(1\u20132):182\u2013197","journal-title":"Int J Pharm"},{"issue":"8","key":"9478_CR20","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1023\/A:1011904311149","volume":"15","author":"A Reichel","year":"1998","unstructured":"Reichel A, Begley DJ (1998) Potential of immobilized artificial membranes for predicting drug penetration across the blood-brain barrier. Pharm Res 15(8):1270\u20131274","journal-title":"Pharm Res"},{"issue":"1","key":"9478_CR21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/ci034205d","volume":"44","author":"M Adenot","year":"2004","unstructured":"Adenot M, Lahana R (2004) Blood-brain barrier permeation models: discriminating between potential CNS and non-CNS drugs including P-glycoprotein substrates. J Chem Inf Comput Sci 44(1):239\u2013248","journal-title":"J Chem Inf Comput Sci"},{"key":"9478_CR22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.pharmtox.43.100901.140204","volume":"43","author":"AG Boer de","year":"2003","unstructured":"de Boer AG, van der Sandt ICJ, Gaillard PJ (2003) The role of drug transporters at the blood-brain barrier. Annu Rev Pharmacol Toxicol 43:629\u2013656","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"12","key":"9478_CR23","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.addr.2004.07.009","volume":"56","author":"ECM Lange de","year":"2004","unstructured":"de Lange ECM (2004) Potential role of ABC transporters as a detoxification system at the blood-CSF barrier. Adv Drug Deliv Rev 56(12):1793\u20131809","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"9478_CR24","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.tips.2010.03.003","volume":"31","author":"DS Miller","year":"2010","unstructured":"Miller DS (2010) Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier. Trends Pharmacol Sci 31(6):246\u2013254","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"9478_CR25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/153537020523000206","volume":"230","author":"B Bauer","year":"2005","unstructured":"Bauer B, Hartz AMS, Fricker G, Miller DS (2005) Modulation of p-glycoprotein transport function at the blood-brain barrier. Exp Biol Med 230(2):118\u2013127","journal-title":"Exp Biol Med"},{"issue":"2\u20133","key":"9478_CR26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0169-409X(98)00085-4","volume":"36","author":"AH Schinkel","year":"1999","unstructured":"Schinkel AH (1999) P-Glycoprotein, a gatekeeper in the blood-brain barrier. Adv Drug Deliv Rev 36(2\u20133):179\u2013194","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"9478_CR27","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/j.2042-7158.1997.tb06072.x","volume":"49","author":"JA Gratton","year":"1997","unstructured":"Gratton JA, Abraham MH, Bradbury MW, Chadha HS (1997) Molecular factors influencing drug transfer across the blood-brain barrier. J Pharm Pharmacol 49(12):1211\u20131216","journal-title":"J Pharm Pharmacol"},{"issue":"8","key":"9478_CR28","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1007\/s11095-008-9584-5","volume":"25","author":"S Kortagere","year":"2008","unstructured":"Kortagere S, Chekmarev D, Welsh WJ, Ekins S (2008) New predictive models for blood-brain barrier permeability of drug-like molecules. Pharm Res 25(8):1836\u20131845","journal-title":"Pharm Res"},{"issue":"7","key":"9478_CR29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1023\/A:1027359714663","volume":"17","author":"MC Hutter","year":"2003","unstructured":"Hutter MC (2003) Prediction of blood-brain barrier permeation using quantum chemically derived information. J Comput Aided Mol Des 17(7):415\u2013433","journal-title":"J Comput Aided Mol Des"},{"issue":"2","key":"9478_CR30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0378-5173(00)00422-1","volume":"201","author":"M Feher","year":"2000","unstructured":"Feher M, Sourial E, Schmidt JM (2000) A simple model for the prediction of blood-brain partitioning. Int J Pharm 201(2):239\u2013247","journal-title":"Int J Pharm"},{"issue":"10","key":"9478_CR31","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1023\/A:1015040217741","volume":"16","author":"J Kelder","year":"1999","unstructured":"Kelder J, Grootenhuis PDJ, Bayada DM, Delbressine LPC, Ploemen J-P (1999) Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs. Pharm Res 16(10):1514\u20131519","journal-title":"Pharm Res"},{"issue":"9","key":"9478_CR32","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/jps.2600830915","volume":"83","author":"MH Abraham","year":"1994","unstructured":"Abraham MH, Chadha HS, Mitchell RC (1994) Hydrogen bonding. 33. Factors that influence the distribution of solutes between blood and brain. J Pharm Sci 83(9):1257\u20131268","journal-title":"J Pharm Sci"},{"issue":"7","key":"9478_CR33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10822-005-9001-7","volume":"19","author":"SR Mente","year":"2005","unstructured":"Mente SR, Lombardo F (2005) A recursive-partitioning model for blood\u2013brain barrier permeation. J Comput Aided Mol Des 19(7):465\u2013481","journal-title":"J Comput Aided Mol Des"},{"issue":"8","key":"9478_CR34","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.ejmech.2007.11.011","volume":"43","author":"S Bendels","year":"2008","unstructured":"Bendels S, Kansy M, Wagner B, Huwyler J (2008) In silico prediction of brain and CSF permeation of small molecules using PLS regression models. Eur J Med Chem 43(8):1581\u20131592","journal-title":"Eur J Med Chem"},{"issue":"3","key":"9478_CR35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0169-409X(02)00005-4","volume":"54","author":"U Norinder","year":"2002","unstructured":"Norinder U, Haeberlein M (2002) Computational approaches to the prediction of the blood-brain distribution. Adv Drug Deliv Rev 54(3):291\u2013313","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"9478_CR36","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1021\/ci980411n","volume":"39","author":"JM Luco","year":"1999","unstructured":"Luco JM (1999) Prediction of the brain\u00a0\u2212\u00a0blood distribution of a large set of drugs from structurally derived descriptors using partial least-squares (PLS) modeling. J Chem Inf Comput Sci 39(2):396\u2013404. doi: 10.1021\/ci980411n","journal-title":"J Chem Inf Comput Sci"},{"issue":"11","key":"9478_CR37","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1021\/jm990968+","volume":"43","author":"P Crivori","year":"2000","unstructured":"Crivori P, Cruciani G, Carrupt PA, Testa B (2000) Predicting blood-brain barrier permeation from three-dimensional molecular structure. J Med Chem 43(11):2204\u20132216","journal-title":"J Med Chem"},{"issue":"5","key":"9478_CR38","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1021\/ci050135u","volume":"45","author":"H Li","year":"2005","unstructured":"Li H, Yap CW, Ung CY, Xue Y, Cao ZW, Chen YZ (2005) Effect of selection of molecular descriptors on the prediction of blood-brain barrier penetrating and nonpenetrating agents by statistical learning methods. J Chem Inf Model 45(5):1376\u20131384. doi: 10.1021\/ci050135u","journal-title":"J Chem Inf Model"},{"issue":"9","key":"9478_CR39","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/qsar.200960008","volume":"28","author":"Z Wang","year":"2009","unstructured":"Wang Z, Yan A, Yuan Q (2009) Classification of blood-brain barrier permeation by Kohonen\u2019s self-organizing neural network (KohNN) and support vector machine (SVM). QSAR Comb Sci 28(9):989\u2013994","journal-title":"QSAR Comb Sci"},{"issue":"8","key":"9478_CR40","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1007\/s11095-008-9609-0","volume":"25","author":"L Zhang","year":"2008","unstructured":"Zhang L, Zhu H, Oprea TI, Golbraikh A, Tropsha A (2008) QSAR modeling of the blood-brain barrier permeability for diverse organic compounds. Pharm Res 25(8):1902\u20131914","journal-title":"Pharm Res"},{"issue":"11","key":"9478_CR41","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/jcc.20437","volume":"27","author":"B Hemmateenejad","year":"2006","unstructured":"Hemmateenejad B, Miri R, Safarpour MA, Mehdipour AR (2006) Accurate prediction of the blood-brain partitioning of a large set of solutes using ab initio calculations and genetic neural network modeling. J Comput Chem 27(11):1125\u20131135","journal-title":"J Comput Chem"},{"issue":"7","key":"9478_CR42","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/qsar.200320004","volume":"22","author":"M Teixido","year":"2003","unstructured":"Teixido M, Belda I, Rosello X, Gonzalez S, Fabre M, Llora X, Bacardit J, Garrell JM, Vilaro S, Albericio F, Giralt E (2003) Development of a genetic algorithm to design and identify peptides that can cross the blood-brain barrier 1. Design and validation in silico. QSAR Comb Sci 22(7):745\u2013753. doi: 10.1002\/qsar.200320004","journal-title":"QSAR Comb Sci"},{"issue":"8","key":"9478_CR43","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/j.bmc.2005.01.061","volume":"13","author":"R Narayanan","year":"2005","unstructured":"Narayanan R, Gunturi SB (2005) In silico ADME modelling: prediction models for blood-brain barrier permeation using a systematic variable selection method. Bioorgan Med Chem 13(8):3017\u20133028. doi: 10.1016\/j.bmc.2005.01.061","journal-title":"Bioorgan Med Chem"},{"issue":"1","key":"9478_CR44","first-page":"115","volume":"12","author":"M Vastag","year":"2009","unstructured":"Vastag M, Keser\u00fc GM (2009) Current in vitro and in silico models of blood-brain barrier penetration: a practical view. Curr Opin Drug Discov Dev 12(1):115\u2013124","journal-title":"Curr Opin Drug Discov Dev"},{"issue":"4","key":"9478_CR45","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1021\/jm701122q","volume":"51","author":"MP Gleeson","year":"2008","unstructured":"Gleeson MP (2008) Generation of a set of simple, interpretable ADMET rules of thumb. J Med Chem 51(4):817\u2013834. doi: 10.1021\/jm701122q","journal-title":"J Med Chem"},{"issue":"2","key":"9478_CR46","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1124\/mi.3.2.90","volume":"3","author":"WM Pardridge","year":"2003","unstructured":"Pardridge WM (2003) Blood-brain barrier drug targeting: the future of brain drug developement. Mol Interv 3(2):90\u2013105. doi: 10.1124\/mi.3.2.90","journal-title":"Mol Interv"},{"issue":"6","key":"9478_CR47","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1021\/ci010290i","volume":"41","author":"R Liu","year":"2001","unstructured":"Liu R, Sun H, So S\u2013S (2001) Development of quantitative structure\u00a0\u2212\u00a0property relationship models for early ADME evaluation in drug discovery. 2. Blood-brain barrier penetration. J Chem Inf Comput Sci 41(6):1623\u20131632. doi: 10.1021\/ci010290i","journal-title":"J Chem Inf Comput Sci"},{"issue":"10","key":"9478_CR48","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1016\/j.bmcl.2009.03.109","volume":"19","author":"MJ Waring","year":"2009","unstructured":"Waring MJ (2009) Defining optimum lipophilicity and molecular weight ranges for drug candidates\u2013Molecular weight dependent lower logD limits based on permeability. Bioorg Med Chem Lett 19(10):2844\u20132851","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"9478_CR49","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s11095-010-0303-7","volume":"28","author":"X Liu","year":"2011","unstructured":"Liu X, Testa B, Fahr A (2011) Lipophilicity and its relationship with passive drug permeation. Pharm Res 28(5):962\u2013977. doi: 10.1007\/s11095-010-0303-7","journal-title":"Pharm Res"},{"issue":"3","key":"9478_CR50","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1021\/ci900431f","volume":"50","author":"C Kramer","year":"2010","unstructured":"Kramer C, Beck B, Clark T (2010) A surface-integral model for log POW. J Chem Inf Model 50(3):429\u2013436. doi: 10.1021\/ci900431f","journal-title":"J Chem Inf Model"},{"issue":"9","key":"9478_CR51","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1021\/ci200276v","volume":"51","author":"M Muehlbacher","year":"2011","unstructured":"Muehlbacher M, Kerdawy AE, Kramer C, Hudson B, Clark T (2011) Conformation-dependent QSPR models: logPOW. J Chem Inf Model 51(9):2408\u20132416. doi: 10.1021\/ci200276v","journal-title":"J Chem Inf Model"},{"issue":"5","key":"9478_CR52","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/jps.22404","volume":"100","author":"MH Abraham","year":"2010","unstructured":"Abraham MH (2010) The permeation of neutral molecules, ions, and ionic species through membranes: brain permeation as an example. J Pharm Sci 100(5):1690\u20131701. doi: 10.1002\/jps.22404","journal-title":"J Pharm Sci"},{"issue":"3","key":"9478_CR53","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s002329900434","volume":"165","author":"H Fischer","year":"1998","unstructured":"Fischer H, Gottschlich R, Seelig A (1998) Blood-brain barrier permeation: molecular parameters governing passive diffusion. J Membr Biol 165(3):201\u2013211","journal-title":"J Membr Biol"},{"issue":"1","key":"9478_CR54","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1021\/ci000043z","volume":"41","author":"GM Keseru","year":"2000","unstructured":"Keseru GM, Molnar L (2000) High-throughput prediction of blood\u00a0\u2212\u00a0brain partitioning: a thermodynamic approach. J Chem Inf Comput Sci 41(1):120\u2013128. doi: 10.1021\/ci000043z","journal-title":"J Chem Inf Comput Sci"},{"issue":"1","key":"9478_CR55","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12031-007-0055-y","volume":"33","author":"A Seelig","year":"2007","unstructured":"Seelig A (2007) The role of size and charge for blood-brain barrier permeation of drugs and fatty acids. J Mol Neurosci 33(1):32\u201341","journal-title":"J Mol Neurosci"},{"issue":"6","key":"9478_CR56","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1021\/ci0600814","volume":"46","author":"G Gerebtzoff","year":"2006","unstructured":"Gerebtzoff G, Seelig A (2006) In silico prediction of blood-brain barrier permeation using the calculated molecular cross-sectional area as main parameter. J Chem Inf Model 46(6):2638\u20132650. doi: 10.1021\/Ci0600814","journal-title":"J Chem Inf Model"},{"issue":"17","key":"9478_CR57","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1016\/j.bmcl.2008.07.071","volume":"18","author":"JD Hughes","year":"2008","unstructured":"Hughes JD, Blagg J, Price DA, Bailey S, DeCrescenzo GA, Devraj RV, Ellsworth E, Fobian YM, Gibbs ME, Gilles RW, Greene N, Huang E, Krieger-Burke T, Loesel J, Wager T, Whiteley L, Zhang Y (2008) Physiochemical drug properties associated with in vivo toxicological outcomes. Bioorg Med Chem Lett 18(17):4872\u20134875","journal-title":"Bioorg Med Chem Lett"},{"issue":"20","key":"9478_CR58","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/jm000942e","volume":"43","author":"P Ertl","year":"2000","unstructured":"Ertl P, Rohde B, Selzer P (2000) Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 43(20):3714\u20133717","journal-title":"J Med Chem"},{"issue":"4\u20135","key":"9478_CR59","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1093-3263(00)00068-1","volume":"18","author":"P Labute","year":"2000","unstructured":"Labute P (2000) A widely applicable set of descriptors. J Mol Graph Model 18(4\u20135):464\u2013477","journal-title":"J Mol Graph Model"},{"key":"9478_CR60","doi-asserted-by":"crossref","unstructured":"Molecular Operating Environment MOE 2010.10 (2010)","DOI":"10.1016\/S1464-2859(10)70067-5"},{"issue":"23\u201324","key":"9478_CR61","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.drudis.2010.10.003","volume":"15","author":"Q Li","year":"2010","unstructured":"Li Q, Cheng T, Wang Y, Bryant SH (2010) PubChem as a public resource for drug discovery. Drug Discov Today 15(23\u201324):1052\u20131057","journal-title":"Drug Discov Today"},{"issue":"1\u20133","key":"9478_CR62","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46(1\u20133):3\u201326","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"9478_CR63","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jmgm.2010.03.010","volume":"28","author":"S Vilar","year":"2010","unstructured":"Vilar S, Chakrabarti M, Costanzi S (2010) Prediction of passive blood-brain partitioning: straightforward and effective classification models based on in silico derived physicochemical descriptors. J Mol Graph Model 28(8):899\u2013903","journal-title":"J Mol Graph Model"},{"issue":"9","key":"9478_CR64","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0223-5234(01)01269-7","volume":"36","author":"JA Platts","year":"2001","unstructured":"Platts JA, Abraham MH, Zhao YH, Hersey A, Ijaz L, Butina D (2001) Correlation and prediction of a large blood-brain distribution data set\u2014an LFER study. Eur J Med Chem 36(9):719\u2013730","journal-title":"Eur J Med Chem"},{"issue":"10","key":"9478_CR65","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/jps.20595","volume":"95","author":"MH Abraham","year":"2006","unstructured":"Abraham MH, Ibrahim A, Zhao Y, Acree WE (2006) A data base for partition of volatile organic compounds and drugs from blood\/plasma\/serum to brain, and an LFER analysis of the data. J Pharm Sci 95(10):2091\u20132100","journal-title":"J Pharm Sci"},{"issue":"1","key":"9478_CR66","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1021\/ci050303i","volume":"46","author":"P Garg","year":"2006","unstructured":"Garg P, Verma J (2006) In silico prediction of blood brain barrier permeability: an artificial neural network model. J Chem Inf Model 46(1):289\u2013297","journal-title":"J Chem Inf Model"},{"issue":"5","key":"9478_CR67","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/qsar.200710019","volume":"27","author":"A Guerra","year":"2008","unstructured":"Guerra A, P\u00e1ez JA, Campillo NE (2008) Artificial neural networks in ADMET modeling: prediction of blood-brain barrier permeation. QSAR Comb Sci 27(5):586\u2013594","journal-title":"QSAR Comb Sci"},{"issue":"3","key":"9478_CR68","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/ci010127n","volume":"42","author":"K Rose","year":"2002","unstructured":"Rose K, Hall LH, Kier LB (2002) Modeling blood-brain barrier partitioning using the electrotopological state. J Chem Inf Comput Sci 42(3):651\u2013666","journal-title":"J Chem Inf Comput Sci"},{"issue":"4","key":"9478_CR69","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1021\/ci700100f","volume":"47","author":"DA Konovalov","year":"2007","unstructured":"Konovalov DA, Coomans D, Deconinck E, Vander Heyden Y (2007) Benchmarking of QSAR models for blood-brain barrier permeation. J Chem Inf Model 47(4):1648\u20131656","journal-title":"J Chem Inf Model"},{"issue":"2","key":"9478_CR70","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10822-008-9243-2","volume":"23","author":"M Zerara","year":"2009","unstructured":"Zerara M, Brickmann J, Kretschmer R, Exner TE (2009) Parameterization of an empirical model for the prediction of n-octanol, alkane and cyclohexane\/water as well as brain\/blood partition coefficients. J Comput Aided Mol Des 23(2):105\u2013111","journal-title":"J Comput Aided Mol Des"},{"issue":"4","key":"9478_CR71","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1021\/ci049971e","volume":"44","author":"Y Xue","year":"2004","unstructured":"Xue Y, Yap CW, Sun LZ, Cao ZW, Wang JF, Chen YZ (2004) Prediction of P-glycoprotein substrates by a support vector machine approach. J Chem Inf Comput Sci 44(4):1497\u20131505. doi: 10.1021\/ci049971e","journal-title":"J Chem Inf Comput Sci"},{"issue":"3","key":"9478_CR72","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1021\/ci050041k","volume":"45","author":"Y-H Wang","year":"2005","unstructured":"Wang Y-H, Li Y, Yang S-L, Yang L (2005) Classification of substrates and inhibitors of P-glycoprotein using unsupervised machine learning approach. J Chem Inf Model 45(3):750\u2013757. doi: 10.1021\/ci050041k","journal-title":"J Chem Inf Model"},{"issue":"1","key":"9478_CR73","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/mp0499196","volume":"2","author":"MVS Varma","year":"2004","unstructured":"Varma MVS, Sateesh K, Panchagnula R (2004) Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport. Mol Pharm 2(1):12\u201321. doi: 10.1021\/mp0499196","journal-title":"Mol Pharm"},{"key":"9478_CR74","unstructured":"Advanced Chemistry Development Inc (2010) ACD\/PhysChem. version 10.0 edn, Toronto"},{"issue":"6","key":"9478_CR75","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10822-008-9209-4","volume":"22","author":"G Purvis","year":"2008","unstructured":"Purvis G (2008) Size-intensive descriptors. J Comput Aided Mol Des 22(6):461\u2013468","journal-title":"J Comput Aided Mol Des"},{"issue":"4","key":"9478_CR76","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/qsar.200510200","volume":"25","author":"C Andres","year":"2006","unstructured":"Andres C, Hutter MC (2006) CNS permeability of drugs predicted by a decision tree. QSAR Comb Sci 25(4):305\u2013309","journal-title":"QSAR Comb Sci"},{"issue":"2","key":"9478_CR77","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ejpb.2008.05.005","volume":"70","author":"X-C Fu","year":"2008","unstructured":"Fu X-C, Wang G-P, Shan H-L, Liang W-Q, Gao J-Q (2008) Predicting blood-brain barrier penetration from molecular weight and number of polar atoms. Eur J Pharm Biopharm 70(2):462\u2013466","journal-title":"Eur J Pharm Biopharm"},{"key":"9478_CR78","unstructured":"Furcy D, Koenig S (2005) Limited discrepancy beam search. Paper presented at the Proceedings of the 19th international joint conference on Artificial intelligence, Edinburgh, Scotland"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10822-011-9478-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T09:36:37Z","timestamp":1741944997000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-011-9478-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,23]]},"references-count":78,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["9478"],"URL":"https:\/\/doi.org\/10.1007\/s10822-011-9478-1","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,23]]}}}